References
- 1. Cao W, Li T. COVID-19: towards understanding of pathogenesis. Cell Res 2020; 30: 367-369.
- 2. Lurie N, Saville M, Hatchett R, Halton J. Developing Covid-19 Vaccines at Pandemic Speed. New England Journal of Medicine. 2020; 382(21): 1969-1973.
- 3. Phelan J, Deelder W, Ward D et al. Controlling the SARS-CoV-2 outbreak, insights from large scale whole genome sequences generated across the world. bioRxiv 2020.04.28.066977; 2020; doi.org/10.1101/2020.04.28.066977.
- 4. Arokiaraj MC, Menesson E. Novel anti-inflammatory and immunomodulation effects of Rose on the endothelium in normal and hypoxic invitro conditions. Angiologia e Cirurgia Vascular. 2019; 15(4): 238-248.
- 5. Ackermann M, Verleden S, Kuehnel M et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. New England Journal of Medicine. 2020; 383(2):120-128.
- 6. Hariri L, Hardin C. Covid-19, Angiogenesis, and ARDS Endotypes. New England Journal of Medicine. 2020; 383(2):182-183.
- 7. Hoffmann M, Kleine-Weber H, Schroeder S et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020; 181(2): 271-280.e8.
- 8. Yan R, Zhang Y, Li Y et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020; 367(6485): 1444-1448.
- 9. Carrasco-Hernandez R, Jácome R, López Vidal Y, Ponce de León S. Are RNA Viruses Candidate Agents for the Next Global Pandemic? A Review. ILAR Journal. 2017; 58(3): 343-358.
- 10. Coperchini F, Chiovato L, Croce L et al. The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system. Cytokine & Growth Factor Reviews. 2020; 53:25-32.
- 11. George P, Wells A, Jenkins R. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. The Lancet Respiratory Medicine. 2020; 8(8):807-815.